Prenatal caffeine exposure induced a lower level of fetal blood leptin mainly via placental mechanism

Toxicol Appl Pharmacol. 2015 Nov 15;289(1):109-16. doi: 10.1016/j.taap.2015.09.007. Epub 2015 Sep 12.

Abstract

It's known that blood leptin level is reduced in intrauterine growth retardation (IUGR) fetus, and placental leptin is the major source of fetal blood leptin. This study aimed to investigate the decreased fetal blood leptin level by prenatal caffeine exposure (PCE) and its underlying placental mechanisms. Pregnant Wistar rats were intragastrically administered caffeine (30-120 mg/kg day) from gestational day 9 to 20. The level of fetal serum leptin and the expression of placental leptin-related genes were analyzed. Furthermore, we investigated the molecular mechanism of the reduced placental leptin's expression by treatment with caffeine (0.8-20 μM) in the BeWo cells. In vivo, PCE significantly decreased fetal serum leptin level in caffeine dose-dependent manner. Meanwhile, placental mRNA expression of adenosine A2a receptor (Adora2a), cAMP-response element binding protein (CREB), a short-type leptin receptor (Ob-Ra) and leptin was reduced in the PCE groups. In vitro, caffeine significantly decreased the mRNA expression of leptin, CREB and ADORA2A in concentration and time-dependent manners. The addition of ADORA2A agonist or adenylyl cyclase (AC) agonist reversed the inhibition of leptin expression induced by caffeine. PCE induced a lower level of fetal blood leptin, which the primary mechanism is that caffeine inhibited antagonized Adora2a and AC activities to decreased cAMP synthesis, thus inhibited the expression of the transcription factor CREB and target gene leptin in the placenta. Meantime, the reduced transportation of maternal leptin by placental Ob-Ra also contributed to the reduced fetal blood leptin. Together, PCE decreased fetal blood leptin mainly via reducing the expression and transportation of leptin in the placenta.

Keywords: Adenosine A2a receptor (ADORA2A),; Intrauterine growth retardation (IUGR);; Leptin;; Placenta;; Pregnancy caffeine exposure;; Transportation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylyl Cyclases / genetics
  • Adenylyl Cyclases / metabolism
  • Animals
  • Caffeine / administration & dosage
  • Caffeine / adverse effects*
  • Cells, Cultured
  • Colforsin / pharmacology
  • Cyclic AMP Response Element-Binding Protein / genetics
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Down-Regulation
  • Female
  • Fetal Blood / chemistry
  • Fetal Development / drug effects
  • Fetal Growth Retardation / chemically induced
  • Fetal Growth Retardation / pathology
  • Fetus / drug effects
  • Humans
  • Leptin / blood*
  • Leptin / genetics
  • Leptin / metabolism
  • Male
  • Maternal Exposure*
  • Placenta / drug effects*
  • Pregnancy
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Receptor, Adenosine A2A / genetics
  • Receptor, Adenosine A2A / metabolism*
  • Receptors, Leptin / genetics
  • Receptors, Leptin / metabolism

Substances

  • Creb1 protein, rat
  • Cyclic AMP Response Element-Binding Protein
  • Leptin
  • RNA, Messenger
  • Receptor, Adenosine A2A
  • Receptors, Leptin
  • Colforsin
  • Caffeine
  • Adenylyl Cyclases